Comprehensive infrastructure is essential to driving research progress and improving patient care. In this podcast, A/Prof Sydney Ch’ng leads an insightful discussion on the...

Neoadjuvant immunotherapy is transforming patient care in the field of melanoma. New research recently presented at the American Society of Clinical Oncology (ASCO) Annual...

Biomarkers are revolutionising our understanding of melanoma by providing valuable information about a patient’s unique tumour characteristics which can help guide clinical decision making....

Mucosal melanoma is a rare and aggressive form of melanoma that arises from the mucous membrane. In this podcast, we focus on mucosal melanoma...

In this recorded meeting hosted by Pierre Fabre and chaired by MIA’s A/Prof Alexander Menzies, you will hear the panel discuss 3 cases that...

In this recorded webinar from Melanoma Institute Australia (MIA) and the Australasian Society of Plastic Surgeons (ASPS), you will hear our panel from different...

There are a number of studies now showing that the gut microbiome directly impacts the systemic immune system and thus can influence both toxicity...

Diagnostic uncertainty in the context of cutaneous melanoma can have significant impact on patient care. In this podcast, our multidisciplinary experts, led by Dr...

In-transit melanoma are intradermal and subcutaneous metastases located between the primary site and regional lymph node basin. In this brief recorded presentation, MIA’s Surgical...